The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - Biological Psychiatry
Receptores de los opioides
Scientists Just Solved a Major Piece of the Opioid Puzzle | WIRED
Kappa Opioid Receptor Internalization Assay - Innoprot GPCR Assays
Table II from Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. | Semantic Scholar
Kappa opioid receptor labeled with Tb (HTRF transiently expressing cells)
Kappa Opioid Receptor Structure Revealed, A Potential Milestone in Medication Development | Maine Suboxone Treatment
Amazon.com: Participação dos receptores kappa-opioides centrais na ingestão de sal: Ação dos opioides centrais sobre a regulação do controle hidroeletrolítico (Portuguese Edition): 9783841719379: Reis Nascimento, Ana Isabel: Libros
Opioid Hedonic Hotspot in Nucleus Accumbens Shell: Mu, Delta, and Kappa Maps for Enhancement of Sweetness “Liking” and “Wanting” | Journal of Neuroscience
Anti-Kappa Opioid Receptor antibody - N-terminal (ab194371) | Abcam
Peripheral Kappa Opioid Receptor Signaling Takes on a Central Role - ScienceDirect
κ-opioid receptor - Wikipedia
Human RANkL CLIA Kit | Receptor Activator of Nuclear Factor Kappa B Ligand CLIA | stjohnslabs
Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway | Cell Communication and Signaling | Full Text
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis - ScienceDirect
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Opioid receptors | Introduction | BPS/IUPHAR Guide to PHARMACOLOGY
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library
